Betoptic 0.25% suspension eye drops Velika Britanija - angleščina - MHRA (Medicines & Healthcare Products Regulatory Agency)

betoptic 0.25% suspension eye drops

sigma pharmaceuticals plc - betaxolol hydrochloride - eye drops - 2.5mg/1ml

Betoptic 0.5% eye drops Velika Britanija - angleščina - MHRA (Medicines & Healthcare Products Regulatory Agency)

betoptic 0.5% eye drops

de pharmaceuticals - betaxolol hydrochloride - eye drops - 5mg/1ml

Betoptic 0.25% suspension eye drops Velika Britanija - angleščina - MHRA (Medicines & Healthcare Products Regulatory Agency)

betoptic 0.25% suspension eye drops

de pharmaceuticals - betaxolol hydrochloride - eye drops - 2.5mg/1ml

Betoptic 0.5% w/v Eye Drops, Solution Irska - angleščina - HPRA (Health Products Regulatory Authority)

betoptic 0.5% w/v eye drops, solution

imbat limited - betaxolol hydrochloride - eye drops, solution - 0.5 base %w/v - beta blocking agents1); betaxolol

DORZOLAMIDE HYDROCHLORIDE solution/ drops Združene države Amerike - angleščina - NLM (National Library of Medicine)

dorzolamide hydrochloride solution/ drops

sandoz inc - dorzolamide hydrochloride (unii: qzo5366ew7) (dorzolamide - unii:9jdx055tw1) - dorzolamide 20 mg in 1 ml - dorzolamide hydrochloride ophthalmic solution, 2% is indicated in the treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma. dorzolamide hydrochloride ophthalmic solution is contraindicated in patients who are hypersensitive to any component of this product [see warnings and precautions (5.1)]. there are no adequate and well-controlled studies in pregnant women with dorzolamide hydrochloride ophthalmic solution. dorzolamide caused fetal vertebral malformations when administered orally to rabbits at 2.5 mg/kg/day (37 times the clinical exposure). dorzolamide administered during the period of organogenesis was not teratogenic in rabbits dosed up to 1 mg/kg/day (15 times the clinical exposure). dorzolamide hydrochloride administered orally to rats during late gestation and lactation caused growth delays in offspring at 7.5 mg/kg/day (52 times the clinical exposure). growth was not delayed at 1 mg/kg/day (8.0 times the clinical exposure). the background risk of maj

BETOPTIC 0.5 %w/v Eye Drops Solution Irska - angleščina - HPRA (Health Products Regulatory Authority)

betoptic 0.5 %w/v eye drops solution

g & a licensing limited - betaxolol hydrochloride - eye drops solution - 0.5 %w/v

BETOPTIC SUSPENSION SINGLE DOSE 0.25 %w/v Eye Drops Suspension Irska - angleščina - HPRA (Health Products Regulatory Authority)

betoptic suspension single dose 0.25 %w/v eye drops suspension

alcon laboratories (uk) ltd - betaxolol hydrochloride - eye drops suspension - 0.25 %w/v - beta blocking agents

BETOPTIC 0.5 %w/v Eye Drops Solution Irska - angleščina - HPRA (Health Products Regulatory Authority)

betoptic 0.5 %w/v eye drops solution

novartis pharmaceuticals uk ltd - betaxolol hydrochloride - eye drops solution - 0.5 %w/v - beta blocking agents

BETOPTIC SUSPENSION SINGLE DOSE 0.25 %w/v Eye Drops Suspension Irska - angleščina - HPRA (Health Products Regulatory Authority)

betoptic suspension single dose 0.25 %w/v eye drops suspension

novartis pharmaceuticals uk ltd - betaxolol hydrochloride - eye drops suspension - 0.25 %w/v - beta blocking agents

BETOPTIC S-STERILE OPHTHALMIC SUSPENSION 5ML Malezija - angleščina - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

betoptic s-sterile ophthalmic suspension 5ml

novartis corporation (malaysia) sdn. bhd. - betaxolol hydrochloride -